Press Release: Sebela Pharmaceuticals : Organon Enters into Agreement to License MIUDELLA, Sebela Pharmaceuticals' Hormone-Free Intrauterine Device

Press Release: Sebela Pharmaceuticals : Sebela Pharmaceuticals Announces Submission of New Drug Application to FDA for Tegoprazan for the Treatment of Gastroesophageal Reflux Disease

Sebela Pharmaceuticals: Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela's Bowel Prep Franchise to Azurity

Press Release: Sebela Pharmaceuticals : MIUDELLA Hormone-Free Copper Intrauterine System (IUS) Phase 3 Data Publication in Contraception Honored with Daniel Mishell, Jr. MD Outstanding Article Award at Society of Family Planning Annual Meeting

Press Release: Sebela Pharmaceuticals : Sebela Women's Health's MIUDELLA Hormone-Free Copper Intrauterine System (IUS) Named to TIME's List of the Best Inventions of 2025

Press Release: Sebela Pharmaceuticals : Sebela Pharmaceuticals Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 24-Week Maintenance Phase Results

Sebela Pharmaceuticals: Sebela Pharma announces positive results from phase 3 TRIUMpH programme of tegoprazan in GERD